AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

AMPHOTERICINE B

8 registrations across 4 African markets— 6 active

Markets with AMPHOTERICINE B

Recent registrations

Brand / ProductMarketHolderStatusExpires
AMPHONEX 50MG POUDRE LYOPHILISE POUR PERFUSION EN IV BOITE DE 1🇨🇮Côte d'IvoireBHARAT SERUMS & VACCINES LIMITEDactiveFeb 2029
FUNGIZONE
Pdre p.prep.injectable / 50 MG
🇹🇳TunisiaBRISTOL MYERS SQUIBBexpiredJan 1994
FUNGIZONE
Suspension buvable / 10%
🇹🇳TunisiaBRISTOL MYERS SQUIBBexpiredJan 1994
FUNGIZONE
POUDRE POUR SOLUTION INJECTABLE
🇲🇦Moroccoactive
AMPHOTRET 50MG PDRE LYO PERF IV BTE (1 FL) BHARAT SERUMS &
poudre lyophilisée pour
🇲🇬MadagascarBHARAT SERUM AND VACCINESactive
FUNGIZONE
LOTION
🇲🇦Moroccoactive
FUNGIZONE
SUSPENSION BUVABLE
🇲🇦Moroccoactive
AMPHOTRET 50MG PDRE LYO PERF IV BTE (1 FL) BHARAT SERUMS &
poudre lyophilisée pour
🇲🇬MadagascarBHARAT SERUM AND VACCINESactive

AMPHOTERICINE B in Africa — Regulatory Overview

AMPHOTERICINE B is registered across 4 African markets with 8 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Morocco, Madagascar, Tunisia, Côte d'Ivoire. AfricaRegulatory refreshes this data daily from official government sources.

Of the 8 registrations, 6 (75%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.